Our research strongly supports the notion that the ELK3-CYFIP2 axis acts as a actin remodeling regulator that drives metastasis of TNBC, influencing both cancer cell migration and immune sensitivity to NK cells. The gene discussed is CYFIP2; the disease is cancer.